Skip to Main Content

Paper Details

Cost Effectiveness of a CYP2C19 Genotype-Guided Strategy in Patients with Acute Myocardial Infarction: Results from the POPular Genetics Trial.
American Journal of Cardiovascular Drugs
10
2022
Acute Myocardial Infarction, CYP2C19, P2Y12, Patients, myocardial infarction, patients, prasugrel, thrombotic events, ticagrelor
Author NameAffiliation
Pim van der HarstUniversity Medical Center Groningen
Pim van der HarstUniversity Medical Center Utrecht, Utrecht University
Vera H M DeneerUtrecht Institute for Pharmaceutical Sciences, Utrecht University
Vera H M DeneerUniversity Medical Center Utrecht
  • 1 - 4

Datasets

Release 1.2